G1 Therapeutics, Inc.
Pyrimidine-based compounds for the treatment of cancer
Last updated:
Abstract:
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
Status:
Grant
Type:
Utility
Filling date:
21 Dec 2018
Issue date:
14 Apr 2020